Figure 1. Patient Flow Diagram.

^aDiscontinuation for the following reasons: COVID-19, death, met the criteria of treatment discontinuation, prohibited anticancer therapy during treatment, or withdrew from study treatment and continued survival follow-up.

^bThe intention-to-treat (ITT) analysis set included all randomized patients analyzed according to their randomized treatment arm.

^cThe safety analysis set included all patients who received at least 1 dose of study drug analyzed according to the study treatment received.